An overview of monoamine oxidase inhibitors. Introductory remarks
Burrows, D.
Journal of Neural Transmission. Supplementum 28: 1-3
1989
ISSN/ISBN: 0303-6995 PMID: 2677239 Document Number: 331576
Document emailed within 1 workday
Related Documents
Garcia, J.A. 1971: Monoamine oxidase inhibitors Revista Brasileira de Medicina 28(4): 143-146Larsen, J.K. 1981: Monoamine oxidase inhibitors Ugeskrift for Laeger 143(24): 1549-1552
Arai, Y.; Matsumoto, K.; Kamijo, K. 1972: Monoamine oxidase. 16. Purification of monoamine oxidase from beef liver mitochondria and its enzymatic properties Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 68(4): 400-409
Kooy, A.; Peters-Romeyn, B.M.; van Gool, A.R. 1993: Monoamine oxidase inhibitors: poisoning and interactions Nederlands Tijdschrift Voor Geneeskunde 137(38): 1910-1914
O'Brien, S.; McKeon, P. 1989: Monoamine oxidase inhibitors--new insights into old problems Irish Medical Journal 82(4): 146-147
Pare, C.M. 1963: Potentiation of Monoamine-Oxidase Inhibitors by Tryptophan Lancet 2(7306): 527-528
Nabatame, E. 1971: Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 67(4): 374-386
Fallon, B.; Foote, B.; Walsh, B.T.; Roose, S.P. 1988: 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors Journal of Clinical Psychiatry 49(4): 163-165
Lippmann, S.B.; Manshadi, M.S.; Gultekin, A. 1985: Monoamine oxidase inhibitors for depressed cardiac patients Journal of Clinical Psychiatry 46(12): 545-546
Maeda, I.; Ueda, T.; Koide, R.; Inatomi, M.; Fukado, Y.; Uchida, E.; Oguchi, K.; Yasuhara, H. 1988: Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit Japanese Journal of Ophthalmology 32(2): 211-218
Robinson, D.S. 1986: New perspectives on long-standing issues: the monoamine oxidase inhibitors Psychopharmacology Bulletin 22(1): 12-15
Finberg, J.P. 1995: Pharmacology of reversible and selective inhibitors of monoamine oxidase type A Acta Psychiatrica Scandinavica. Supplementum 386: 8-13
Stoliarova, L.G.; Kadykov, A.S.; Shvedkov, V.V.; Shakhparonova, N.V. 1988: Experience using selective monoamine oxidase inhibitors in treating parkinsonism patients Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(12): 11-13
Goldman, L.S.; Alexander, R.C.; Luchins, D.J. 1986: Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects Journal of Clinical Psychiatry 47(5): 225-229
Medvedev, A.E.; Ivanov, A.S.; Veselovsky, A.V. 2000: Selective inhibitors and computer modelling of the active site of monoamine oxidase Neurobiology 8(2): 201-214
Cockhill, L.A.; Remick, R.A. 1987: Blood pressure effects of monoamine oxidase inhibitors--the highs and lows Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 32(9): 803-808
Ossowska, G.; Klenk-Majewska, B.; Danilczuk, Z.; Wróbel, A.; Zebrowska-Lupina, I. 1999: Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors Polish Journal of Pharmacology 51(5): 391-397
Martin, Y.C.; Biel, J.H. 1974: Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase Advances in Biochemical Psychopharmacology 12(0): 37-48
Pitchot, W.; Scantamburlo, G.; Ansseau, M. 2011: Tricyclic antidepressants and monoamine oxidase inhibitors - do they still have a role in the treatment of depression? Revue Medicale de Liege 66(3): 144-152
Kumar, Y.; Florvall, L.; Ask, A.L.; Ross, S.B.; Holm, A.C.; Ogren, S.O. 1983: Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane Acta Pharmaceutica Suecica 20(5): 349-364